Article
Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
International journal of oncology - 1 Apr 2010
De Moura Juliana, Kavalec Flávia Ludimila, Doghman Mabrouka, Rosati Roberto, Custodio Gislaine, Lalli Enzo, Cavallari Glaci Moura D, Santa Maria Jesus, Figueiredo Bonald C
Abstract excerpt
The Li-Fraumeni syndrome (LFS) is a rare autosomal dominant hereditary cancer syndrome, characterized by a wide spectrum of neoplasms, occurring in children and young adults. The identification of germline TP53 mutations in LFS has given rise to a number of in vitro studies using cultures of cancer cells and non-tumoral fibroblasts presenting germline TP53 mutations. In the present study, we performed a detailed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
